- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04697797
Mechanical and Electrical Dyssynchrony During His-Bundle Pacing Versus His-Bundle Area Right Ventricular Pacing
Mechanical and Electrical Dyssynchrony During His-Bundle Pacing (Selective and Non-selective) Versus His-Bundle Area Right Ventricular Pacing
Study Overview
Detailed Description
Permanent His Bundle Pacing (HBP) is a well-known method of cardiac pacing which is increasingly used in everyday practice. After lead implantation in His Bundle area (HBA) capture of various tissues can be achieved: A. right ventricular myocardium near to HBP; B. cardiac conduction system selectively or nonselectively (with concomitant regional myocardium activation). The different excitability and refractory periods decide which tissue, myocardium or/and the conduction system is effectively paced. A lot of clinical trials revealed the advantage of HBP over apical ventricular pacing (AVP). HBP improves clinical (NYHA, quality of life, hospitalization rate) and echocardiographic (left ventricular dimension and ejection fraction) indicators of heart failure.
We are going to compare mechanical and electrical synchrony during the various type of myocardium activation: HBP (nsHBP or sHBP), RV pacing near HBA and native heart rhythm (if possible) in each patient recruited to the study. Adequate pacemaker programming will allow achieving different activations as shown above. The mechanical synchrony will be estimated by transthoracic echocardiography and the electrical one by the detailed analysis of ECG.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Krzysztof A Kaczmarek, MD, PhD
- Phone Number: +48 42 201 43 60
- Email: krzysztof.kaczmarek@umed.lodz.pl
Study Locations
-
-
-
Lodz, Poland, 93-216
- Recruiting
- Department of Electrocardiology Medical University of Lodz
-
Contact:
- Krzysztof A Kaczmarek, MD, PhD
- Phone Number: +48 42 201 43 60
- Email: krzysztof.kaczmarek@umed.lodz.pl
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- all adult patients after implantation of pacemaker system with pacing lead successfully captured His Bundle (selectively or/and nonselectively)
Exclusion Criteria:
- not willing or incapable to give written informed consent;
- previous implanted cardiac electronic device (pacemaker, implantable cardioverter-defibrillator, cardiac resynchronization therapy device)
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Interventricular mechanical delay
Time Frame: Mid-term: 3-6 months after pacemaker implantation
|
InterVentricular Mechanical Dyssynchrony Parameter 1
|
Mid-term: 3-6 months after pacemaker implantation
|
|
Interventricular mechanical delay
Time Frame: Long term: 12-15 months after pacemaker implantation
|
InterVentricular Mechanical Dyssynchrony Parameter 1
|
Long term: 12-15 months after pacemaker implantation
|
|
Free-wall-LV-to-RV-delay
Time Frame: Mid-term: 3-6 months after pacemaker implantation
|
InterVentricular Mechanical Dyssynchrony Parameter 2
|
Mid-term: 3-6 months after pacemaker implantation
|
|
Free-wall-LV-to-RV-delay
Time Frame: Long term: 12-15 months after pacemaker implantation
|
InterVentricular Mechanical Dyssynchrony Parameter 2
|
Long term: 12-15 months after pacemaker implantation
|
|
Septal-to-posterior wall motion delay
Time Frame: Mid-term: 3-6 months after pacemaker implantation
|
IntraVentricular Mechanical Dyssynchrony Parameter 1
|
Mid-term: 3-6 months after pacemaker implantation
|
|
Septal-to-posterior wall motion delay
Time Frame: Long term: 12-15 months after pacemaker implantation
|
IntraVentricular Mechanical Dyssynchrony Parameter 1
|
Long term: 12-15 months after pacemaker implantation
|
|
Opposing wall motion delay
Time Frame: Long term: 12-15 months after pacemaker implantation
|
IntraVentricular Mechanical Dyssynchrony Parameter 2
|
Long term: 12-15 months after pacemaker implantation
|
|
Opposing wall motion delay
Time Frame: Mid-term: 3-6 months after pacemaker implantation
|
IntraVentricular Mechanical Dyssynchrony Parameter 2
|
Mid-term: 3-6 months after pacemaker implantation
|
|
systolic dyssynchrony index
Time Frame: Long term: 12-15 months after pacemaker implantation
|
Ventricular Mechanical Dyssynchrony Parameter 1
|
Long term: 12-15 months after pacemaker implantation
|
|
systolic dyssynchrony index
Time Frame: Mid-term: 3-6 months after pacemaker implantation
|
Ventricular Mechanical Dyssynchrony Parameter 1
|
Mid-term: 3-6 months after pacemaker implantation
|
|
QRS duration
Time Frame: Mid-term: 3-6 months after pacemaker implantation
|
Electrical dyssynchrony Parameter
|
Mid-term: 3-6 months after pacemaker implantation
|
|
QRS duration
Time Frame: Long term: 12-15 months after pacemaker implantation
|
Electrical dyssynchrony Parameter
|
Long term: 12-15 months after pacemaker implantation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Radial strain
Time Frame: Mid-term: 3-6 months after pacemaker implantation
|
Additional Ventricular Mechanical Dyssynchrony Parameter 1
|
Mid-term: 3-6 months after pacemaker implantation
|
|
Radial strain
Time Frame: Long term: 12-15 months after pacemaker implantation
|
Additional Ventricular Mechanical Dyssynchrony Parameter 1
|
Long term: 12-15 months after pacemaker implantation
|
|
Left Ventricular Ejection Fraction
Time Frame: Mid-term: 3-6 months after pacemaker implantation
|
Global left ventricle function parameter
|
Mid-term: 3-6 months after pacemaker implantation
|
|
Left Ventricular Ejection Fraction
Time Frame: Long term: 12-15 months after pacemaker implantation
|
Global left ventricle function parameter
|
Long term: 12-15 months after pacemaker implantation
|
|
Global longitudinal strain
Time Frame: Mid-term: 3-6 months after pacemaker implantation
|
Global left ventricle function parameter 2
|
Mid-term: 3-6 months after pacemaker implantation
|
|
Global longitudinal strain
Time Frame: Long term: 12-15 months after pacemaker implantation
|
Global left ventricle function parameter 2
|
Long term: 12-15 months after pacemaker implantation
|
|
Left ventricular output track velocity-time integral
Time Frame: Mid-term: 3-6 months after pacemaker implantation
|
Global left ventricle function parameter 3
|
Mid-term: 3-6 months after pacemaker implantation
|
|
Left ventricular output track velocity-time integral
Time Frame: Long term: 12-15 months after pacemaker implantation
|
Global left ventricle function parameter 3
|
Long term: 12-15 months after pacemaker implantation
|
|
Diastolic Filling Time
Time Frame: Mid-term: 3-6 months after pacemaker implantation
|
Atrioventricular Dyssynchrony Parameter
|
Mid-term: 3-6 months after pacemaker implantation
|
|
Diastolic Filling Time
Time Frame: Long term: 12-15 months after pacemaker implantation
|
Atrioventricular Dyssynchrony Parameter
|
Long term: 12-15 months after pacemaker implantation
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RNN/147/20/KE
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bradyarrhythmia
-
Medtronic Cardiac Rhythm and Heart FailureMedtronicCompleted
-
Deutsches Herzzentrum MuenchenCompletedBradyarrhythmiaGermany, Croatia, Japan
-
Medtronic Cardiac Rhythm and Heart FailureCompleted
-
Boston Scientific CorporationCompleted
-
Boston Scientific CorporationCompletedBradyarrhythmiaItaly, France, Netherlands, Belgium, Spain, Germany, United Kingdom, Denmark, Slovakia
-
Medtronic Cardiac Rhythm and Heart FailureMedtronicCompleted
-
Biotronik Japan, Inc.Completed
-
Haran Burri, MDAbbott Medical DevicesTerminatedBradyarrhythmiaSwitzerland, Netherlands
-
China Medical University HospitalChina Medical University, ChinaUnknown
-
Azienda Ospedaliera Cardinale G. PanicoEnrolling by invitation
Clinical Trials on Device Programming
-
Medical University InnsbruckRecruiting
-
Aston UniversityUniversity Hospital Birmingham NHS Foundation TrustWithdrawnCardiac Failure
-
Montreal Heart InstituteCanadian Institutes of Health Research (CIHR); Abbott Medical DevicesCompleted
-
Hospital Clinic of BarcelonaCompleted
-
MedtronicNeuroCompleted
-
Minneapolis Heart Institute FoundationMinneapolis Heart Institute FoundationWithdrawn
-
Azienda Ospedaliera Universitaria Mater Domini,...CompletedCardiac Resynchronization TherapyItaly
-
CMC Ambroise ParéTerminatedHeart Failure | Cardiac Resynchronization TherapyFrance
-
Washington University School of MedicineTerminatedElectrocardiography | Cardiac Resynchronization Therapy | Systolic Heart FailureUnited States